Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new franchisees over the past year. Speaking to CNBC-TV18, Guha said the company continues to prioritise affordability, with most gains coming from volume and test mix rather than price hikes.
